Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Jaguar Animal Health ( (JAGX) ) is now available.
On January 16, 2026, Jaguar Health executed a series of privately negotiated exchanges with Iliad Research and Trading and Streeterville Capital that reduced outstanding royalty interests and retired portions of its Series L and Series M perpetual preferred stock in return for issuing multiple pre-funded common stock purchase warrants. The transactions cut $1.19 million from an October 2020 royalty interest and $850,000 from an August 2022 royalty interest, and cancelled specified Series L and Series M preferred shares held by the two investors, while creating new pre-funded warrants exercisable at a nominal price and subject to a 9.99% ownership cap, effectively deleveraging the balance sheet at the cost of potential future equity dilution for existing shareholders.
The most recent analyst rating on (JAGX) stock is a Hold with a $0.82 price target. To see the full list of analyst forecasts on Jaguar Animal Health stock, see the JAGX Stock Forecast page.
Spark’s Take on JAGX Stock
According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.
The score is held down primarily by weak financial performance (large ongoing losses, high leverage, and heavy cash burn) and a bearish technical setup (trading below all major moving averages with negative MACD). Corporate events provide a meaningful positive offset via non-dilutive funding and encouraging clinical progress, but not enough to overcome current financial and trend risks.
To see Spark’s full report on JAGX stock, click here.
More about Jaguar Animal Health
Jaguar Health, Inc. is a biopharmaceutical company that finances its operations in part through structured royalty interests and preferred stock issuances, indicating a capital-raising strategy focused on specialized securities and private transactions with institutional investors.
Average Trading Volume: 3,630,414
Technical Sentiment Signal: Sell
Current Market Cap: $3.19M
See more insights into JAGX stock on TipRanks’ Stock Analysis page.